Home LiteratureArticle Details
PMID: 14501003 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment.

Journal of molecular neuroscience : MN ·Vol. 20 ·No. 3 ·2003-00-00 ·Pages 241-8

Grundman M, Jack CR, Petersen RC, Kim HT, Taylor C, Datvian M, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Darvesh S, Yaffe K, Kaye J, Ferris SH, Thomas RG, Thal LJ, Alzheimer's Disease Cooperative Study

Abstract

Mild cognitive impairment (MCI) appears to be a transitional stage in the development of Alzheimer's disease (AD). Patients with MCI show impaired memory performance and hippocampal atrophy relative to normal elderly controls. Prior studies indicate that the degree of hippocampal atrophy in MCI patients predicts conversion to AD. In contrast to patients with MCI who have deficits primarily in memory, AD patients have clinically evident impairments in both memory and nonmemory cognitive domains. One explanation for the observation that a smaller hippocampal volume predicts conversion to AD might be that hippocampal atrophy is associated with early impairment in nonmemory cognitive areas as well as memory. A link between hippocampal volume and nonmemory function could occur if hippocampal atrophy was correlated with AD pathology in other brain regions. We therefore sought to determine the relationship of hippocampal volume with performance on memory and nonmemory tasks in patients with MCI. Although we found a significant correlation between hippocampal volume and memory performance, we did not find a significant correlation between hippocampal volume and nonmemory performance. We conclude that the relationship between hippocampal volume and risk of AD is likely tied to reduced memory performance and not associated with impairment in nonmemory cognitive domains.

MeSH Terms
Aged Atrophy/etiology,pathology,physiopathology Cognition Disorders/pathology,physiopathology,psychology Female Hippocampus/pathology,physiopathology Humans Magnetic Resonance Imaging Male Memory Disorders/pathology,physiopathology,psychology Neuropsychological Tests Statistics as Topic
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
Grundman Michael
Department of Neurosciences, University of California, San Diego, La Jolla 92093-0949, USA. mgrundman@ucsd.edu
Jack Clifford R
Petersen Ronald C
Kim Hyun T
Taylor Curtis
Datvian Marina
Weiner Myron F
DeCarli Charles
DeKosky Steven T
van Dyck Christopher
Darvesh Sultan
Yaffe Kristine
Kaye Jeffrey
Ferris Steven H
Thomas Ronald G
Thal Leon J
Alzheimer's Disease Cooperative Study
References (14)
14 references, click to expand
  1. Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type.
    Arch Neurol. 1992 Dec;49(12):1253-8 PMID: 1449404
  2. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
    Neurology. 1999 Apr 22;52(7):1397-403 PMID: 10227624
  3. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.
    Neurology. 1997 Sep;49(3):786-94 PMID: 9305341
  4. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
    Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S13-21 PMID: 9236948
  5. Mild cognitive impairment: clinical characterization and outcome.
    Arch Neurol. 1999 Mar;56(3):303-8 PMID: 10190820
  6. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease.
    Neurology. 1992 Mar;42(3 Pt 1):631-9 PMID: 1549228
  7. Neuropsychological prediction of decline to dementia in nondemented elderly.
    J Geriatr Psychiatry Neurol. 1999 Winter;12(4):168-79 PMID: 10616864
  8. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.
    Arch Neurol. 1998 Sep;55(9):1185-91 PMID: 9740112
  9. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial.
    J Mol Neurosci. 2002 Aug-Oct;19(1-2):23-7 PMID: 12212787
  10. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.
    JAMA. 1995 Apr 26;273(16):1274-8 PMID: 7646655
  11. Cognitive and neurobiologic markers of early Alzheimer disease.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13547-51 PMID: 8942970
  12. Memory and MRI-based hippocampal volumes in aging and AD.
    Neurology. 2000 Feb 8;54(3):581-7 PMID: 10680786
  13. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
    JAMA. 2000 Mar 22-29;283(12):1571-7 PMID: 10735393
  14. MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies.
    Radiology. 1990 Jul;176(1):205-9 PMID: 2353093
Article Info
Journal
Journal of molecular neuroscience : MN
Abbr.
J Mol Neurosci
ISSN
0895-8696
Published
2003-00-00
Pages
241-8
Language
English
Region
United States
NLM ID
9002991
Subset
IM
Grants
NIA NIH HHS · U19 AG010483 · United States
NIA NIH HHS · AG 10483 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com